- Featured
-
02 Oct 2026
Why European Research Needs a Shared Digital Infrastructure for Project Dissemination
by Ngọc Trần
- Views 812
- More stats
-
03 Sep 2026
Engineering HR Is Looking for a New Owner: A Turnkey Platform for Engineering Talent
by Alen Piljić
- Views 1041
- More stats
-
13 May 2026
Science Events (sci.events) Expands Its Digital Infrastructure for Scientific Meetings: A Call for Sponsorship
by Alen Piljić
- Views 2847
- More stats
-
05 Dec 2025
Life Science Network Expands Its Offerings: Web Development, Data Management, and Visualization Services for Research Organisations and Consortia
by Alen Piljić
- Views 2409
- More stats
-
17 Oct 2026
FDA approves Roche’s Enspryng, a first-in-class IL-6R inhibitor, as the first and only at-home subcutaneous treatment option for thyroid eye disease (TED)
by Roche News Feed
- Views 249
- More stats
-
11 Oct 2026
Roche presents new Phase III one-year data for vamikibart in uveitic macular edema (UME), a serious cause of vision loss
by Roche News Feed
- Views 256
- More stats
-
10 Oct 2026
FDA approves Roche’s Tecentriq in combination with a fluoropyrimidine and oxaliplatin for the adjuvant treatment of a certain type of stage III colon cancer
by Roche News Feed
- Views 243
- More stats
-
01 Oct 2026
Roche presents new data at EURETINA, highlighting Vabysmo’s real-world effectiveness and safety across major retinal conditions
by Roche News Feed
- Views 315
- More stats
-
01 Oct 2026
Roche’s giredestrant combination significantly improved progression-free survival in ER-positive advanced breast cancer in phase III evERA data published in The New England Journal of Medicine
by Roche News Feed
- Views 394
- More stats
-
01 Oct 2026
Roche’s fenebrutinib is the first BTK inhibitor to receive U.S. FDA filing acceptance in both relapsing and primary progressive multiple sclerosis
by Roche News Feed
- Views 375
- More stats
-
01 Oct 2026
Change in Roche’s Board of Directors
by Roche News Feed
- Views 279
- More stats
-
01 Oct 2026
Positive interim data shows Roche’s sefaxersen significantly reduces proteinuria in people with IgA nephropathy (IgAN)
by Roche News Feed
- Views 182
- More stats
-
01 Oct 2026
[Ad hoc announcement pursuant to Art. 53 LR] Roche announces positive Phase II results for dual GLP-1/GIP receptor agonist enicepatide in people living with type 2 diabetes and overweight or obesity
by Roche News Feed
- Views 348
- More stats
-
01 Oct 2026
European Commission approves Roche’s Susvimo® for the treatment of neovascular age-related macular degeneration (nAMD)
by Roche News Feed
- Views 134
- More stats
Latest News in Life Sciences
Read the latest news, announcements and press releases from life sciences and related disciplines, including news from biotechnology and pharmaceutical research and development. When you join Life Science Network, you can follow your favorite sources to get notified when content matching your interests is published.
You can post a news article here
Join Life Science Network
Join LSN to acces all jobs and fully benefit from the platform and its features.
News module
Are you interested in posting articles on Life Science Network?
Please continue reading here.
For more information about Life Science Network,
contact us at [email protected].
Advertisement